EUVIMEDAtrasti EUVIMED
Open access · CC BY 4.0

Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell‐of‐origin model for osteoid osteoma and osteoblastoma

Suk Wai Lam iD, Tatiana Belova, Natasja Franceschini, Brendy van den Akker, David Gp van IJzendoorn, Harald Mm Mikkers, Hailiang Mei, Anne-Marie Cleton-Jansen iD, Marieke L Kuijjer, Karoly Szuhai iD, Judith Vmg Bovée iD

The Journal of Pathology · 2026

DOI: 10.1002/path.70010 ↗

At a glance

Journal article in The Journal of Pathology, 2026. Written by Suk Wai Lam and 10 co-authors. Institution: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. Major MEDLINE topics: Osteogenesis, Osteoma, Osteoid, Cell Differentiation, Osteoblastoma. 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: ZonMw.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Osteoid osteoma and osteoblastoma are non‐malignant bone‐forming tumours of the skeleton, characterised by the presence of irregular trabeculae of woven bone. Rearrangements in FOS, and less frequently FOSB , have recently been identified in osteoid osteoma and osteoblastoma. Identical rearrangements in FO S were previously detected in epithelioid haemangioma, where these led to truncation of the FOS protein in the C‐terminal domain, causing increased protein stability due to impaired degradation. Since FOS plays a role in osteogenic differentiation, the effect of FOS truncation on osteogenic differentiation and proliferation was investigated in an in vitro model for osteoid osteoma and osteoblastoma. In this model, truncated FOS (FOSΔ) was overexpressed in human foetal mesenchymal stem cells through a lentiviral vector. Osteogenic differentiation — assessed by measuring mineralisation, ALPL expression, and ALP activity — and proliferation rate were reduced in cells overexpressing FOSΔ compared to mesenchymal stem cells with an empty lentiviral vector (pLV). Transcriptome‐sequencing and differential gene expression analysis revealed decreased gene expression of genes in pathways involving cell cycling and mitosis and osteogenic differentiation, including WNT signalling, extracellular matrix organisation, and matrix metalloproteinases (MMPs), in FOSΔ as compared to empty vector cells, indicating decreased proliferation and osteogenesis. Instead, FOSΔ cells showed upregulation of genes involved in prostaglandin signalling and NF‐kB inflammatory pathways. These findings highlight that FOSΔ compromises cellular growth and osteogenesis, which is in line with the morphological features of osteoid osteoma and osteoblastoma with woven bone formation instead of mature lamellar bone, as well as the indolent clinical behaviour. Additionally, FOSΔ promotes inflammatory signalling instead, which correlates with clinically exquisite response to non‐steroid anti‐inflammatory drugs. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

OsteogenesisOsteoma, OsteoidCell DifferentiationOsteoblastomaNF-kappa BBone NeoplasmsProto-Oncogene Proteins c-fosHumansSignal TransductionMesenchymal Stem CellsCell Proliferation

Author keywords

FOSmesenchymal stem cellosteoblastomaosteogenic differentiationosteoid osteomatruncated FOS

Substances

NF-kappa BProto-Oncogene Proteins c-fosFOS protein, human

Authors and institutions

  • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway.
  • Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Biomedical Data Sciences, Sequencing Analysis Support Core, Leiden University Medical Center, Leiden, The Netherlands.
  • iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.

ORCID profiles: Suk Wai Lam, Anne-Marie Cleton-Jansen, Karoly Szuhai, Judith Vmg Bovée

Funding

  • ZonMw

Cite

APA

Lam, S. W., Belova, T., Franceschini, N., van den Akker, B., van IJzendoorn, D. G., Mikkers, H. M., Mei, H., Cleton-Jansen, A. M., Kuijjer, M. L., Szuhai, K., & Bovée, J. V. (2026). Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell‐of‐origin model for osteoid osteoma and osteoblastoma. The Journal of Pathology. https://doi.org/10.1002/path.70010

Vancouver

Lam SW, Belova T, Franceschini N, van den Akker B, van IJzendoorn DG, Mikkers HM, et al. Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell‐of‐origin model for osteoid osteoma and osteoblastoma. The Journal of Pathology. 2026. doi:10.1002/path.70010

BibTeX
@article{Lam2026,
  author = {Lam, Suk Wai and Belova, Tatiana and Franceschini, Natasja and van den Akker, Brendy and van IJzendoorn, David Gp and Mikkers, Harald Mm and Mei, Hailiang and Cleton-Jansen, Anne-Marie and Kuijjer, Marieke L and Szuhai, Karoly and Bovée, Judith Vmg},
  title = {Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell‐of‐origin model for osteoid osteoma and osteoblastoma},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70010}
}
Start for free →